BILL Holdings, Inc. (NYSE: BILL) shares are trading lower on Thursday following a report suggesting the company is nearing a deal to acquire Melio Payments.
Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced